First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
The company has entered into a three-year Deferred Prosecution Agreement
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Jeet will be a trusted partner in cardiovascular care
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Subscribe To Our Newsletter & Stay Updated
